musculoskeletal disorders Flashcards
1
Q
Juvenile idiopathic arthritis
A
- JIA is not a single disease, as the rterm includes all forms of childhood arthritis
2
Q
three systems used to diagnose and classify childhood arthritis
A
- American college of Rheumatology criteria for JIA
- European League against rheumatism criteria for JIA
- international league of associations for rheumatology criteria for JIA
3
Q
diagnosis of JIA
A
- defined as persistent arthritis lasting at least 6 weeks in one or more joints in a child younger than 16 years of age when all other cuases are eliminated
- etiology- genetic predisposition with external trigger
4
Q
Systemic JIA
A
- 4-17% cases
- M=F onset throughout childhood
- spiking fever 1-2 times/day for at least 2 weeks. fever typically accompanied by an evanescent rash on trunk or limbs
- systemic signs: pleuritic, pericarditid, myocarditis, hepatosplenomegaly, lymphadenopathy
5
Q
polyarticular JIA
A
- RF positive: onset 2-4 and 6 to 12
RF neg: onset late childhood or adolescence - arthritis in 5 or more joints: symmetrical. affecting both large and small joints. joints are swollen and warm but rarely red
-rheumatoid nodules on elbows, tibial crests and fingers. less common in RF negative
6
Q
Oligoarticular JIA
A
- 27-56% of children with JIA
- onset in early childhood peak at 2-4 years
- female> male
- low grade inflammation in 4 or fewer joints
- joints are swollen and may be warm
- systemic signs unusual
7
Q
Primary clinical manifestation
A
- joint swelling, pain, and stiffness
-morning stiffness - muscle atrophy, weakness poor muscle endurance
- ## systemic manifestation
8
Q
secondary clinical manifestation
A
- limited joint motion; soft tissue contracture
- fatigue
- decreased aerobic capacity
- growth abnormalities
- osteopenia; osteoporosis
- difficulties with ADL
- participation restriction
9
Q
medical management
- NSAIDS
A
- most widely used first line therapy
- -naproxen, tolmetin and ibuprofen at emost common
- reduce fever, pain and inflammation, but do not alter the course of the disease
10
Q
medical management
- methotrexate
A
- most common disease modifying antirheumatic drug
- prescribed to children with poly and systemic JIA
- weekly oral administration
11
Q
goal of pharmacologic therapy
A
- control arthritis; preventing joint erosion
- manage extra articular manifestation
12
Q
PT intervention in acute phase
A
- maintaining and preserving joint function
- RICE- avoid heat, US and diathermy
- splinting
13
Q
PT intervention in subacute and chronic
A
- restoration and compensation of cuntion and activities
- balance rest and exercise
14
Q
aerobic fitness prescription
A
- 2x/week for 45-60 mins of moderate to vigorous intensity
15
Q
resistance training prescription
A
- 2x week. light weights with 2-3 sets to 10-15 reps
- use isometrics with acute joint inflammation
- progress to concentric and eccentric as inflammation subsides
16
Q
athrogryposis multiplex congenital defined
A
- a non-progressive neuromuscular syndrome present at birth that is characterized by severe joint contractures, muscle weakness and fibrosis
- prescence of contractures in 2 or more body areas
-children bright and motivated